[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

About

Aims and scope

Journal of Inflammation welcomes research submissions on all aspects of inflammation.

The five classical symptoms of inflammation, namely redness (rubor), swelling (tumour), heat (calor), pain (dolor) and loss of function (functio laesa), are only part of the story. The term inflammation is taken to include the full range of underlying cellular and molecular mechanisms involved, not only in the initiation and propagation of inflammation in order to defend against infection, but also in the resolution of inflammation and associated repair processes. Thus the journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings.

Journal of Inflammation aims to become the leading online journal on inflammation and, as online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids in promoting dynamic and productive dialogue between industrial and academic members of the inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies.

Open access

All articles published by Journal of Inflammation are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here

As authors of articles published in Journal of Inflammation you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article according to the licence terms

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article processing charges (APC)

Authors who publish open access in Journal of Inflammation are required to pay an article processing charge (APC). The APC price will be determined from the date on which the article is accepted for publication.

The current APC, subject to VAT or local taxes where applicable, is: £2390.00/$3290.00/€2790.00

Visit our open access support portal and our Journal Pricing FAQs for further information.

Open access funding

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

Springer Nature offers APC waivers and discounts for articles published in our fully open access journals whose corresponding authors are based in the world’s lowest income countries (see our APC waivers and discounts policy for further information). Requests for APC waivers and discounts from other authors will be considered on a case-by-case basis, and may be granted in cases of financial need (see our open access policies for journals for more information). All applications for discretionary APC waivers and discounts should be made at the point of manuscript submission; requests made during the review process or after acceptance are unable to be considered.

2025 APCs

For information about the APC applicable for articles accepted for publication next year, please see our journal lists.

Indexing services

All articles published in Journal of Inflammation are included in:

  • Biological Abstracts
  • BIOSIS
  • CABI
  • CAS
  • Citebase
  • DOAJ
  • Embase
  • EmBiology
  • Global Health
  • Google Scholar
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • SCImago
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Journal of Inflammation operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Prior to January 2010 the journal operated under a policy of open peer review, meaning that a 'pre-publication history' including signed reviews was published alongside the articles. If you wish to request details of the pre-publication history for an article published during this time, please contact journals@biomedcentral.com.

Edited by Paul Kirkham and Adriano Rossi, Journal of Inflammation is supported by an expert Editorial Board. Publication of research articles by Journal of Inflammation is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field.

Editorial policies

All manuscripts submitted to Journal of Inflammation should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Journal of Inflammation

Articles in Journal of Inflammation  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. J Inflamm [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Inflamm 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.

Benefits of publishing with BMC

High visibility

Journal of Inflammation's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Journal of Inflammation offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Journal of Inflammation gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Journal of Inflammation are included in article alerts and regular email updates. Some may be highlighted on Journal of Inflammation’s pages and on the BMC homepage.

In addition, articles published in Journal of Inflammation may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Inflammation. A list of articles recently press-released by journals published by BMC is available here.

Copyright

As an author of an article published in Journal of Inflammation you retain the copyright of your article and you are free to reproduce and disseminate your work. For further information, see our guide to licensing, copyright and author rights

For further information about the advantages of publishing in a journal from BMC, please click here.

New Content Item

Affiliated with the British Inflammation Research Association (BIRAs).

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.4
    5-year Journal Impact Factor: 4.6
    Source Normalized Impact per Paper (SNIP): 0.770
    SCImago Journal Rank (SJR): 0.932

    Speed 2023
    Submission to first editorial decision (median days): 14
    Submission to acceptance (median days): 113

    Usage 2023
    Downloads: 462,203
    Altmetric mentions: 675